An experimental approach to the choice of antiarrhythmic therapy.
D000638:Amiodarone / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control; D002415:Cats; D003327:Coronary Disease / Q000150:complications; D004110:Diltiazem / Q000627:therapeutic use; D008012:Lidocaine / Q000627:therapeutic use; D008801:Mexiletine / Q000627:therapeutic use; D009543:Nifedipine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011405:Propafenone; D011427:Propiophenones / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013233:Stellate Ganglion; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D011427:Propiophenones; D010643:Phenoxybenzamine; D008801:Mexiletine; D011405:Propafenone; D008012:Lidocaine; D011433:Propranolol; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D000638:Amiodarone; D011224:Prazosin